Patents in Class 514/149

Matches 1 - 43 out of 43

Match	Document	Document Title
1	8106034	Angiotensin II receptor antagonists A compound having the structure wherein R is an angiotensin receptor blocking groupY is —(CR1R20)1-7R5, or —C(O)(CR1R20)1-7R5;R1 and R20 are independently selected from the group consisting of hyd...
2	8101589	Nitric oxide-releasing molecules This invention relates to compositions comprising carbon-based diazeniumdiolates that release nitric oxide (NO). The carbon-based diazeniumdiolated molecules release NO spontaneously under...
3	7863262	Nitroxyl progenitors in the treatment of heart failure Administration of an HNO/NO− donating compound, such as Angeli's salt, increases myocardial contractility while concomitantly lowering left ventricular preload in subjects experiencing heart f...
4	7829553	Nitric oxide-releasing polymers This invention relates to compositions comprising carbon-based diazeniumdiolates attached to hydrophobic polymers that releases nitric oxide (NO). The carbon-based diazeniumdiolated polymers...
5	7569559	Nitric oxide-releasing molecules This invention relates to compositions comprising carbon-based diazeniumdiolates that release nitric oxide (NO). The carbon-based diazeniumdiolated molecules release NO spontaneously under...
6	7511029	Pesticidal diazene oxide carboxylates Pesticidal compounds having the structural formula wherein: R2 is C1-C6 branched or straight chain alkyl; C1-C4 branched or straight-chain haloalkyl; or C3-C6 cycloalkyl;m is 0, 1, or 2;X is...
7	7452872	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of...
8	7435408	Porous particles comprising excipients for deep lung delivery Improved porous particles for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the porous particles are made of a...
9	7348319	Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same The present invention relates to nitric oxide-releasing amidine diazeniundiolates, compositions comprising same, methods of using same, and a method for preparing same from imidate...
10	7285533	Apo-2 ligand A novel cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is provided. The Apo-2 ligand is believed to be a member of the TNF cytokine family. Compositions including Apo-2...
11	7122529	Compounds that release nitric oxide at controlled rates upon photolysis Chemical compounds which release nitric oxide in a controlled manner upon photolysis with light are provided. These compounds are O2-benzyl, O2-naphthylmethyl and O2-naphthylallyl substituted...
12	7105502	Nitric oxide-releasing imidate and thioimidate diazeniumdiolates The invention provides NO- or NO−-releasing imidate; and thioimidate, diazeniumdiolates, in which the N2O2− functional group is bonded to a carbon atom. The imidate and thioimidate dia...
13	6825181	Aminoisoquinoline derivatives Aminoisoquinoline derivatives of the following formulae or analogs thereof and pharmaceutically acceptable salts thereof are provided. These compounds have an excellent effect of inhibiting...
14	6780854	Orally active androgens Novel, orally active androgens are 7α-substituted Δ14-nandrolone derivatives. The compounds satisfy the general formula: whereinR1 is O, (H,H), (H,OR), NOR, with R being hydrogen, (C1-6) alkyl, o...
15	6407081	Method for inhibiting cytokine production by cells The invention concerns a method for inhibiting cytokine production by cells, in particular animal or human cells, and their secretion, which consists in applying on said cells at least an azo...
16	6306841	Treatment of female sexual dysfunction Methods and formulations for treating female sexual dysfunction are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina,...
17	5952334	Carbocyclic compounds A compound of formula ##STR1## wherein Z is a tetrahydro-pyrano group selected from ##STR2## having antifungal activity in combination with other antifungal agents.
18	5840759	Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric...
19	5837736	Nitric oxide-releasing compounds to sensitive cancerous cells to chemotherapeutic agents The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric...
20	5814656	Selective prevention of organ injury is sepsis and shock using selective release of nitric oxide vulnerable organs A method for the treatment of mammalian tissue injured or at risk of injury during sepsis or shock including the administration to a mammal a diazeniumdiolate which releases a therapeutically...
21	5814667	Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric...
22	5795878	Biocidal compounds their preparation and use A phenylazoxycyanide compound of formula I ##STR1## is useful as an antimicrobial and fungicidal composition. A method for using the antimicrobial and fungicidal compositions, and for manufacturing...
23	5700830	Use of nitric oxide-releasing agents for reducing metastasis risk A method for inhibiting the adherence between cancerous cells and noncancerous structures in a mammal, comprising the administration to the mammal of a nitric oxide-releasing compound containing a...
24	5670537	Method for effecting tumor regression with a low dose, short infusion taxol regimen Taxol dosages of about 135 mg/m2 or greater are administered via infusions of less than 6 hours duration; the method makes it possible to provide taxol infusions on an out-patient basis to patients...
25	5627175	Azoxycyanobenzene compounds The invention is directed to azoxycyanobenzene derivatives of the formula: ##STR1## wherein n is 0-3; each R represents halogen, nitro, cyano, alkyl, haloalkyl, alkoxy, or haloalkoxy; and each R1...
26	5541169	Azoxy compound An azoxy compound represented by the following general formula ##STR1## wherein R1 denotes a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkoxy group, a lower alkoxy-lower alkoxy group...
27	5439897	Azoxycyanobenzene derivatives, compositions containing them and their use as fungicides This invention relates to certain azoxycyanobenzene derivatives of the general formula. ##STR1## in which R represents an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl,...
28	5376679	Bicyclic or tricyclic biocidal compounds Compounds of the general formula ##STR1## where R2 and R3 together, or R3 and R4 together, represent an optionally substituted hydrocarbyloxy chain; the ring is optionally substituted at any or...
29	5366997	Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs There are disclosed cardiovascularly active compounds possessing antihypertensive properties, and pharmaceutical compositions containing these agents and a method of treating cardiovascular...
30	5350744	Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They...
31	5273997	Biocidal compounds The invention provides compounds of general formula ##STR1## wherein m is 0 or 1; each of R1 and R2, and R3 and R4 if present, independently represents a hydrogen or halogen atom or an optionally...
32	5089487	Circulation-active dibenzo[1,5]dioxocin-5-ones Cardioactive compounds of the formula ##STR1## in which R1 and R8 and R14 and R15 can be hydrogen or various organic radicals.
33	5089486	Biocidal azophenyl compounds Compounds of the general formula R--NNX (I)or N-oxides thereof, where R represents on amidophenyl group, and X represents a cyano group, a group --COOH or a salt, ester or amino derivative t...
34	5084448	Fungicidal phenyl azoxime compositions Novel compounds of the general formula ##STR1## where R represents an optionally substituted aryl or heteroaryl group; X represents a hydrogen atom or an amino group or an optionally substituted...
35	5057504	1-heterocyclic bicyclo-octanes Pesticidal bicyclo-octanes are of the formula ##STR1## where R is a substituted or unsubstituted aliphatic or aromatic group, R' and R3 are H or a substituted or unsubstituted aliphatic or aromatic...
36	4997820	Microbicides Novel macrocyclic compounds of the formual I ##STR1## where the dotted line in the 9,10-position is a saturated bond or a double bond, alternatively, and R is hydrogen, methyl or certain acyl...
37	4981954	Novel azoxy compounds and process for production thereof Novel azoxy compounds having antifungal activity and being useful for the treatment of mycoses, represented by the following formula ##STR1## are prepared by culturing a microorganism of...
38	4954526	Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents A method of treating cardiovascular disorders in a mammal, by administering to said mammal an effective amount of a compound of the formula: [R--N(H)N(NO)O--]y Xwherein R is loweralkyl, aryl,...
39	4876274	New class of pesticides comprising 1,4-bis-substituted-2,6,7-trioxabicyclo(2.2.2)octanes A pesticidal composition comprising a compound having the formula R--C(CH2 O)3 C--X wherein R and X are each organic substituents and wherein the compound has an LD50, in micrograms of compound per...
40	4814161	Drug-containing chlorofluorocarbon aerosol propellent formulations Complete dissolution of a wide range of drugs in chlorofluorocarbon aerosol propellents is achieved by the presence of glycerol phosphatides, preferably phosphatidylcholine.
41	H000303	Glycoside-containing agricultural treatment composition This invention describes a composition of matter and a method of treating agricultural substrates in which an active ingredient selected from the group consisting of fungicides, bactericides,...
42	3642990	PROCESS OF INHIBITING TRANSPLANTED MAMMARY ADENOCARCINOMA IN MICE USING POLYHALO (AZO OR AZOXY) BENZENE COMPOUNDS
43	2987436	Para-chloroazoxybenzene pesticide

Matches 1 - 43 out of 43